“…In humans, cerebrospinal noradrenaline and its metabolites increase with age and Alzheimer’s disease (for reviews see Mather, 2021; Weinshenker, 2018). Salivary alpha amylase provides a non-invasive proxy measure of central norepinephrine activity (Warren et al, 2017) and salivary alpha amylase levels also are greater in older than younger adults (Almela et al, 2011; Birditt et al, 2018; Nater et al, 2013; Strahler et al, 2010).…”